According to the latest announcement by Kai Ming Medical -B (Stock Code: 2500), the Company's Board of Directors plans to hold a meeting on Thursday, March 28, 2024, to review and approve the annual results for the year ended December 31, 2023, and will consider whether to issue a final dividend. In addition, the company's shares have been suspended from 23 November 2023 on the Stock Exchange of Hong Kong Limited (HKEx) and the suspension of trading will continue until they comply with the Exchange's Recollection Guidelines. Shareholders and potential investors should be aware of the need to exercise caution when buying and selling our securities. CURRENTLY, THE EXECUTIVE DIRECTORS OF THE COMPANY INCLUDE MR. LIN HAO SHENG, MR. MA LI CHAO AND MS. LIU MEI-WING; NON-EXECUTIVE DIRECTORS ARE MR. ZHANG AO AND MR. WANG WEI; INDEPENDENT NON-EXECUTIVE DIRECTORS ARE MR. HU DING-XU AND MR. SUN CHI WAI.

According to the latest announcement by Kai Ming Medical -B (Stock Code: 2500), the Company's Board of Directors plans to hold a meeting on Thursday, March 28, 2024, to review and approve the annual results for the year ended December 31, 2023, and will consider whether to issue a final dividend. In addition, the company's shares have been suspended from 23 November 2023 on the Stock Exchange of Hong Kong Limited (HKEx) and the suspension of trading will continue until they comply with the Exchange's Recollection Guidelines. Shareholders and potential investors should be aware of the need to exercise caution when buying and selling our securities. CURRENTLY, THE EXECUTIVE DIRECTORS OF THE COMPANY INCLUDE MR. LIN HAO SHENG, MR. MA LI CHAO AND MS. LIU MEI-WING; NON-EXECUTIVE DIRECTORS ARE MR. ZHANG AO AND MR. WANG WEI; INDEPENDENT NON-EXECUTIVE DIRECTORS ARE MR. HU DING-XU AND MR. SUN CHI WAI.